PROCEPT BioRobotics Corporation (PRCT) — Financial statements
Income statement, balance sheet, and cash flow for PROCEPT BioRobotics Corporation — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 308↑37.2% | 224↑64.8% | 136↑81.6% | 75↑117.6% | 34 | |
| Cost of Revenue | 112↑28.0% | 87↑34.2% | 65↑71.7% | 38↑103.8% | 19 | |
| Gross Profit | 196↑43.1% | 137↑93.0% | 71↑91.6% | 37↑133.8% | 16 | |
| Operating Expenses | ||||||
| R&D Expenses | 71↑14.4% | 62↑28.6% | 48↑67.2% | 29↑52.6% | 19 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 229↑33.5% | 171↑30.1% | 132↑48.3% | 89↑74.0% | 51 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 300↑28.4% | 234↑29.7% | 180↑53.0% | 118↑68.2% | 70 | |
| Total Costs & Expenses | 412↑28.3% | 321↑30.9% | 245↑57.5% | 156↑75.7% | 89 | |
| Operating Results | ||||||
| Operating Income | -104↓7.5% | -97↑11.5% | -109↓35.2% | -81↓49.0% | -54 | |
| Depreciation & Amortization | 6↑22.1% | 5↑37.5% | 4↑34.0% | 3↓14.5% | 3 | |
| EBITDA | -97↓18.9% | -82↑16.4% | -98↓24.0% | -79↓56.0% | -51 | |
| EBIT | -104↓19.1% | -87↑14.4% | -102↓24.3% | -82↓51.7% | -54 | |
| Interest & Other Income | ||||||
| Net Interest Income | 9↑28.6% | 7↑88.7% | 4↑232.4% | -3↑53.2% | -6 | |
| Interest Income | 12↑12.2% | 11↑44.3% | 8↑202.4% | 2↑3185.5% | 0.08 | |
| Interest Expense | 4↓14.3% | 4↑4.7% | 4↓22.9% | 5↓10.8% | 6 | |
| Non-Operating Income | 0.00↑100.0% | -9↓29.1% | -7↓682.8% | 1↑1130.6% | -0.12 | |
| Other Income / Expenses | 8↑63.0% | 5↑58.9% | 3↑150.9% | -6↓13.0% | -6 | |
| Income Before Tax | -95↓4.3% | -91↑13.7% | -106↓21.5% | -87↓45.6% | -60 | |
| Income Tax Expense | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -96↓4.5% | -91↑13.7% | -106↓21.5% | -87↓45.6% | -60 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -96↓4.5% | -91↑13.7% | -106↓21.5% | -87↓45.6% | -60 | |
| Bottom-Line Net Income | -96↓4.5% | -91↑13.7% | -106↓21.5% | -87↓45.6% | -60 | |
| EPS (Basic) | -1.72↑1.7% | -1.75↑21.9% | -2.24↓14.3% | -1.96↓43.1% | -1.37 | |
| EPS (Diluted) | -1.72↑1.7% | -1.75↑21.9% | -2.24↓14.3% | -1.96↓43.1% | -1.37 | |
| Weighted Average Shares | 56↑6.6% | 52↑10.3% | 47↑6.4% | 44↑1.6% | 44 | |
| Weighted Average Diluted Shares | 56↑6.6% | 52↑10.3% | 47↑6.4% | 44↑1.6% | 44 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.